Lexicon Pharmaceuticals
LXRX
#7142
Rank
S$0.65 B
Marketcap
S$1.81
Share price
-1.41%
Change (1 day)
90.53%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2025 (TTM): S-$0.26

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is S-$0.25. In 2024 the company made an earnings per share (EPS) of S-$0.83 an increase over its 2023 EPS that were of S-$1.04.

EPS history for Lexicon Pharmaceuticals from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S-$0.26-69.22%
2024S-$0.83-20%
2023S-$1.0431.15%
2022S-$0.79-0%
2021S-$0.7910.91%
2020S-$0.71-145.08%
2019S$1.58-206.09%
2018S-$1.49-5.74%
2017S-$1.58-10.95%
2016S-$1.782640%
2015S-$0.06479-96.34%
2014S-$1.77-2.53%
2013S-$1.81-9.09%
2012S-$2.00

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Eterna Therapeutics
ERNA
S-$99.41 40,273.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
S$56.29-22,963.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
S-$7.70 3,026.32%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$3.52-1,531.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
S$22.47-9,226.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
S-$0.70 184.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
S$5.79-2,452.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
S$3.10-1,357.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
S-$0.97 294.74%๐Ÿ‡บ๐Ÿ‡ธ USA